Sagimet Biosciences Provides Strategic and Corporate Updates

PUBLISHED Monday, April 27, 2026 · sagimet biosciences inc.

AI BRIEFING

⬤ Sagimet Biosciences announces Phase 3 clinical trial of denifanstat for moderate to severe acne
⬤ Denifanstat clinical trial planned for second half of 2026
⬤ Sagimet Biosciences provides strategic and corporate updates